How much funding has AMYLOID SOLUTION raised?

AMYLOID SOLUTION has raised $12.8M in total funding, most recently a Series A round.

Who are AMYLOID SOLUTION's investors?

AMYLOID SOLUTION's investors include T S Investment, WONIK Investment Partners.

Where is AMYLOID SOLUTION headquartered?

AMYLOID SOLUTION is headquartered in Seongnam, South Korea.

What industry is AMYLOID SOLUTION in?

AMYLOID SOLUTION operates in Biotech, Healthcare.

How many employees does AMYLOID SOLUTION have?

AMYLOID SOLUTION has 11-50 employees.

AMYLOID SOLUTION

Erasing Alzheimer's Disease

Seongnam, South Korea · $12.8M raised

Biotech

Healthcare

Headquarters: Seongnam
Employees: 11–50
Business Model: B2B
Website: amyloidsolution.com

Total Funding: $12.8M
Last Round: $12.8M Series AMar 2019
Rounds: 1

About

Amyloid Solution Inc. is a South Korean biotechnology company developing innovative disease-modifying treatments for Alzheimer's disease. The company targets patients at various stages of the disease with diverse pathological alterations, pursuing a comprehensive approach to overcome Alzheimer's through next-generation therapeutics. Amyloid Solution collaborates with world-class experts and has an FDA-tracked Phase 1 candidate (AS-S603) in clinical development.

Summary

AMYLOID SOLUTION is a Biotech company based in Seongnam, South Korea. It has raised $12.8M in total across 1 round, most recently a $12.8M Series A round in Mar 2019. Investors include T S Investment and WONIK Investment Partners.